TrialSiteNews was launched to drive more interest and awareness in clinical research, as well as to develop trust and facilitate engagement of researchers and the public. TrialSite started toward the end of 2018, financed solely by the founder, to create a new disruptive force in the world of biomedical research.
TrialSite emphasizes the trial site organization and its staff, whether a hospital, health system, community clinic, or commercial research center, and the breakthroughs, challenges, best practices, and mishaps, all in a bid to provide more transparency for the broader population as to the nuts and bolts of clinical trials.
Mission & Values
TrialSite’s mission is to drive awareness, introduce transparency, and facilitate engagement among people all over the world, from pharmaceutical professionals and academic researchers to regulators and healthcare professionals along with a wide array of the consuming public.
We value transparency, objectivity, and the scientific method in pursuit of the truth wherever it may lead us.
Management
Daniel O’Connor
Founder / CEO
Mark Hadfield
Head of Digital
Dr. Tom Pitts
Chief Medical
Dr. Erin Stair
Digital Media
Shabnam P. Mohamed
TrialSite Africa
Advisory Committee
Dr. Peter McCullough
Dr. McCullough is a practicing internist, cardiologist, epidemiologist and Professor of Medicine. Dr. McCullough is broadly published on a range of topics >1000 publications and >600 citations in the National Library of Medicine.
Dr. Robert Malone
The inventor of mRNA vaccines and RNA transfection, Dr. Malone has extensive research and development experience in the areas of pre-clinical discovery research, clinical trials, vaccines, gene therapy, bio-defense, and immunology.
